191 related articles for article (PubMed ID: 38363226)
21. CD4
Polak K; Marchal P; Taroni C; Ebel C; Kirstetter P; Kastner P; Chan S
Biochem Biophys Res Commun; 2023 Sep; 674():83-89. PubMed ID: 37413709
[TBL] [Abstract][Full Text] [Related]
22. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
23. The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen.
Wood PJ; Cossens IA
Clin Exp Immunol; 1995 May; 100(2):359-65. PubMed ID: 7743677
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation.
Preglej T; Hamminger P; Luu M; Bulat T; Andersen L; Göschl L; Stolz V; Rica R; Sandner L; Waltenberger D; Tschismarov R; Faux T; Boenke T; Laiho A; Elo LL; Sakaguchi S; Steiner G; Decker T; Bohle B; Visekruna A; Bock C; Strobl B; Seiser C; Boucheron N; Ellmeier W
JCI Insight; 2020 Feb; 5(4):. PubMed ID: 32102981
[TBL] [Abstract][Full Text] [Related]
25. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
Niiya H; Sakai I; Lei J; Azuma T; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
Exp Hematol; 2005 Jul; 33(7):811-8. PubMed ID: 15963857
[TBL] [Abstract][Full Text] [Related]
27. Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways.
Umeshappa CS; Xie Y; Xu S; Nanjundappa RH; Freywald A; Deng Y; Ma H; Xiang J
PLoS One; 2013; 8(6):e64787. PubMed ID: 23785406
[TBL] [Abstract][Full Text] [Related]
28. CD4
Ahrends T; Spanjaard A; Pilzecker B; Bąbała N; Bovens A; Xiao Y; Jacobs H; Borst J
Immunity; 2017 Nov; 47(5):848-861.e5. PubMed ID: 29126798
[TBL] [Abstract][Full Text] [Related]
29. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
30. CD4
Preglej T; Ellmeier W
Immunol Lett; 2022 Jul; 247():27-42. PubMed ID: 35568324
[TBL] [Abstract][Full Text] [Related]
31. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
Ciavarra RP
Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
[TBL] [Abstract][Full Text] [Related]
32. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
33. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
35. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
36. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.
Binder D; Kündig TM
J Immunol; 1991 Jun; 146(12):4301-7. PubMed ID: 1710246
[TBL] [Abstract][Full Text] [Related]
37. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
Karupiah G; Buller RM; Van Rooijen N; Duarte CJ; Chen J
J Virol; 1996 Dec; 70(12):8301-9. PubMed ID: 8970949
[TBL] [Abstract][Full Text] [Related]
38. T-bet is required for protection against vaccinia virus infection.
Matsui M; Moriya O; Yoshimoto T; Akatsuka T
J Virol; 2005 Oct; 79(20):12798-806. PubMed ID: 16188982
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
40. An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Mittal P; Abblett R; Ryan JM; Hagymasi AT; Agyekum-Yamoah A; Svedova J; Reiner SL; St Rose MC; Hanley MP; Vella AT; Adler AJ
J Immunol; 2018 Feb; 200(4):1513-1526. PubMed ID: 29305435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
